Reopened USAntibiotics penicillin facility to relieve US dependence on Chinese antibiotics: Jackson Healthcare
The facility will be able to manufacture and stockpile a five-year supply of amoxicillin for the US
USAntibiotics' recently reopened Bristol, Tennessee penicillin manufacturing facility will relieve US dependence on China for antibiotic supply once it comes online, according to the new owners of the site, Jackson Healthcare.
The plant, formerly owned by Neopharma, had slipped into bankruptcy and ceased operations in 2020 before being purchased by Jackson Healthcare earlier this year.
"As the first doses of USAntibiotics' life-saving drugs move down the assembly line, America will have declared its independence from Chinese antibiotics," said Rick Jackson, founder, CEO, and chairman of Jackson Healthcare. "Our mission is to solve our nation's reliance on foreign Amoxicillin and create a secure stockpile that will stand the test of time."
Upon reopening, USAntibiotics will be the only American company able to manufacture the popular antibiotics commonly known as Amoxil (amoxicillin) and Augmentin (amoxicillin clavulanate).
When the 360,000-sq. ft facility comes online, it will have the capacity to produce 300 million capsules and two billion tablets annually, meeting 100% of US amoxicillin demand, according to Jackson Healthcare.
Thirty percent of all antibiotics prescribed in the US each year are amoxicillin.
The facility can also manufacture and stockpile a five-year supply of amoxicillin for the US, a move that represents a complete reversal of the current situation whereby every dose is sourced from outside the US, primarily China, due to years of declining pharmaceutical production capacity in the US.
Earlier this year, US President Joe Biden ordered a review of crucial US supply chains, including pharmaceuticals.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance